The different charges of the three types of nylon membranes achieve a variety of adsorption characteristics!
The "Biodine (Nylon) Membrane" is an intrinsic hydrophilic 6,6 nylon membrane that achieves high sensitivity and low background, enhancing resolution. It is suitable for nucleic acid blotting and protein ELISA tests. Multiple rounds of hybridization, stripping, and reprobing are possible. It demonstrates excellent performance in detection systems using radioactive substances (Biodine B Membrane) and non-radioactive substances (Biodine A Membrane). 【Features】 ■ Improved detection and resolution due to high sensitivity and low background ■ Multiple rounds of hybridization, stripping, and reprobing are possible ■ Achieves diverse adsorption characteristics with three types of nylon membranes with different charges ■ Suitable for nucleic acid detection ■ Hydrophilic *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
【Specifications (Excerpt)】 ■Media: Nylon 6,6 ■Membrane Thickness ・Biodine A: 5.5–7.0μm ・Biodine B: 5.7–6.7μm ・Biodine C: 11–13μm ・Biodine Plus: 5.7–6.7μm ■Pore Size: 0.2, 0.45μm *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Usage】 ■ Nucleic acid blotting ■ Protein ELISA test *For more details, please refer to the PDF document or feel free to contact us.
Company information
Cytiva and Pall Life Sciences have merged their businesses and will officially launch under the "Cytiva" brand on May 1, 2023. Under our mission of "Advancing therapies, faster," we will integrate both organizations and focus even more on supporting the development and manufacturing of better therapies for patients as a stronger global provider of technologies and services. The new Cytiva will offer a broader and deeper expertise and a rich lineup of products and services to better support various customers involved in research and the manufacturing and development of biopharmaceuticals, enabling them to deliver therapies to patients more quickly, from discovery to delivery. With a rich history spanning several hundred years, Pall Life Sciences and Cytiva, as part of the Danaher Group, will continue to unite to provide better services to our customers.
